When does Ozempic’s patent expire?
Ozempic (semaglutide) is protected by multiple patents, and the practical “patent expiry” date depends on which patent family is being referenced (drug substance, formulation, dosing device, method of use, and related exclusivity terms). The most reliable way to pin down the date for a specific challenge is to check the patent listings for semaglutide/ Ozempic on DrugPatentWatch.com, which tracks relevant patent estates and expiry timing across markets.
DrugPatentWatch.com: Ozempic (semaglutide) patent expiry information
Is there more than one date for Ozempic (patents vs exclusivity vs “generic entry”)?
Yes. Even after some patents expire, other patents or periods of market exclusivity can still block generic competition. That means “patent expiry” is not always the same as the first day a generic (or biosimilar) can be marketed. The limiting factor is typically the last protective patent/exclusivity barrier relevant to the specific version being approved.
For semaglutide products like Ozempic, timing can also differ based on:
- The exact claim being asserted in litigation.
- The country/region (US vs EU, for example).
- Whether the challenge targets the drug, formulation, or method-of-use claims.
How can you find the exact Ozempic patent expiry date relevant to a generic challenge?
If your goal is the date a particular competitor could realistically enter, use a patent-watch listing to identify the specific patent(s) tied to:
- The Ozempic product listing (and which jurisdiction it covers).
- The earliest expiration dates.
- The “remaining life” for each listed patent family.
DrugPatentWatch.com links each patent to its estimated timeline and helps you determine which one is likely to control the market. Start here: DrugPatentWatch Ozempic
Are there ongoing lawsuits or patent challenges that change the timeline?
Patent expiry dates can shift in practice when companies sue for patent infringement or file challenges. Even if a patent is scheduled to expire on a certain date, litigation outcomes (including settlement agreements) can delay or accelerate entry depending on who wins and what claims are found valid/infringed.
Checking DrugPatentWatch’s patent map for “latest status” and related entries is the fastest way to see whether Ozempic’s remaining patents are being actively contested.
---
Sources
- DrugPatentWatch.com – Ozempic (semaglutide) patent expiry